PlainRecalls
ModerateClass IIOngoing

FDA Devices recall · Reported April 13, 2022

Alinity m HBV AMP Kit (US and CE)

There is a potential for misquantitation high results for negative samples.

Recall #
Z-0884-2022
Affected scope
4966 kits, updated 101/17/2023
Initiated
March 4, 2022
Verify with FDA Devices →
View my saved recalls

Abbott Molecular, Inc. recalled Alinity m HBV AMP Kit (US and CE) - a moderate-severity action.

Alinity m HBV AMP Kit (US and CE) was recalled by Abbott Molecular, Inc. in April 13, 2022. Reason: There is a potential for misquantitation high results for negative samples.. Check the official notice for the remedy. Verify recall #Z-0884-2022 with the FDA Devices before acting.

The recall

Abbott Molecular, Inc. issued this moderate-severity FDA Devices recall-There is a potential for misquantitation high results for negative samples..

Moderate
severity level
Class II
classification
April 13, 2022
reported

Sourced from official FDA Devices enforcement records. Verify recall #Z-0884-2022 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This recall's affected scope, documented in the Recall Profile below, stays within a single-region or limited-distribution footprint. Distribution scope (see Distribution below) directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls, 6 from FDA Devices - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Medical Devices recalls over time

Where this recall sits in its category - 41,021 medical devices recalls on record

01,0002,0003,0004,000 20052008201120142017202020232026 1,947
Severity1906864652High severity (most serious)Moderate severityLow severity
Where this agency-classified recall sits among FDA Class I/II/III notices

Of 88,244 recalls with an agency hazard classification, 19,068 are high severity, 64,652 moderate, and 4,524 low. A further 16,179 CPSC/NHTSA recalls have no agency class and are excluded from this split. This recall is classified moderate severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Product description

Alinity m HBV AMP Kit (US and CE)

Reason for recall

There is a potential for misquantitation high results for negative samples.

Recall Profile

Structured summary of the FDA Devices recall record
Attribute Value
Agency U.S. Food and Drug Administration
Severity class Moderate (Class II)
Status Ongoing
Recall number Z-0884-2022
Date reported April 13, 2022
Date initiated March 4, 2022
Recalling firm Abbott Molecular, Inc.
Firm location Des Plaines, IL
Affected scope 4966 kits, updated 101/17/2023
Distribution US consignees - AZ, CA, IL, IN, MA, MI, MO, NH, NJ, NY, OH, SD, TX, and VA OUS consignees - Australia, Austria, Belgium, Brazil, Canada, Columbia, Czech Republic, El Salvador, Estonia, France, Germany, Israel, Italy, Japan, Latvia, Mala…

Profile values are sourced directly from the official FDA Devices enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

  • Check the recall number (Z-0884-2022) and product description against the item you own. Search the archive
  • Confirm the current status with FDA Devices before acting, recall details can be updated.
  • Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Devices record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled?
Alinity m HBV AMP Kit (US and CE). Recalled by Abbott Molecular, Inc.. Units affected: 4966 kits, updated 101/17/2023.
Why was this product recalled?
There is a potential for misquantitation high results for negative samples.
Which agency issued this recall?
This recall was issued by the FDA Devices on April 13, 2022. Severity: Moderate. Recall number: Z-0884-2022.
Where was the recalled product distributed?
Distribution: US consignees - AZ, CA, IL, IN, MA, MI, MO, NH, NJ, NY, OH, SD, TX, and VA OUS consignees - Australia, Austria, Belgium, Brazil, Canada, Columbia, Czech Republic, El Salvador, Estonia, France, Germany, Israel, Italy, Japan, Latvia, Malaysia, Netherlands, New Zealand, Norway, Pakistan, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, United Kingdom, and Vietnam.
Should I stop using a recalled medication or medical device?
Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nationwide recalls with similar severity or category timing

Drug and device notices outside this firm and state, matched by severity timing and product category.

Similar Medical Devices · nearest report date

Same product category, closest by report date among other firms and states (deduped against the severity set).

Compare this recall with GORE VIABIL Short Wire Biliary Endoprosthesis, Model No. VS… → · All Medical Devices recalls

This recall: FDA Devices, reported April 13, 2022. Severity classes follow each agency's own taxonomy; related-recall context is computed across the full archive.

Methodology · Corrections · Archive as of August 2026